NCT05449197View on ClinicalTrials.gov

Evaluation of the Training Program for Community Pharmacists for Dispensing Emicizumab (HEMLIBRA®) in France

CompletedOBSERVATIONAL

Enrollment

363

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 30, 2022

Study Completion Date

January 5, 2023

Conditions

Hemophilia A

Interventions

OTHER

HEMOPHAR e-learning program

training on professional practice by following HEMOPHAR e-learning program

Trial Locations (1)

69677

Hospices Civils de Lyon, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER